|
|
|
|
|
|
|
|
|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q/A
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the Quarter Ended Commission File Number
- --------------------- ----------------------
June 30, 1996 33-16757-D
MEDIZONE CANADA LIMITED
(Exact name of registrant as specified in its charter)
Utah 87-0431771
(State or other jurisdiction (I.R.S. Employer
of incorporation Identification No.)
or organization)
123 East 54th Street
Suite 7B
New York, New York 10022
(212) 421-0303
(Address, including zip code and telephone number, including area code of
registrant's principal executive offices)
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
Yes |X| No | |
At August 9, 1996, there were outstanding 36,493,333 shares of the registrant's
common stock.
Page 1 of 3 pages
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
MEDIZONE CANADA LIMITED
-----------------------
(Registrant)
/s/Arthur P. Bergeron
---------------------
Arthur P. Bergeron
Vice President
and Chief Financial Officer
October 2, 1996
Page 2 of 3 pages
<PAGE>
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
(This schedule contains summary financial information extracted from (A)
Interim Consolidaated Balanace Sheets, Statements of Operations, Change in
Stockholders Equity and Cash Flows and is qualified in its entirety by reference
to such (B) quarterly report on Form 10-Q for the six months ended June 30,
1996)
</LEGEND>
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-1996
<PERIOD-END> JUN-30-1996
<CASH> 0
<SECURITIES> 0
<RECEIVABLES> 0
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 0
<PP&E> 0
<DEPRECIATION> 0
<TOTAL-ASSETS> 0
<CURRENT-LIABILITIES> 9,498
<BONDS> 0
0
0
<COMMON> 36,493
<OTHER-SE> (45,991)
<TOTAL-LIABILITY-AND-EQUITY> 0
<SALES> 0
<TOTAL-REVENUES> 0
<CGS> 0
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 744
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> (744)
<INCOME-TAX> 0
<INCOME-CONTINUING> (744)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (744)
<EPS-PRIMARY> 0
<EPS-DILUTED> 0
</TABLE>
|
|